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CORRECT ION Open Ac c e s s
Correction: Rivastigmine modifies the α-secretase
pathway and potentially early Alzheimer’s disease
Balmiki Ray, Bryan Maloney , Kumar Sambamurti, Hanuma K. Karnati, Peter T. Nelson, Nigel H. Greig and
Debomoy K. Lahiri
Correction to: Translational Psychiatry
https://doi.org/10.1038/s41398-020-0709-x
published online 03 February 2020
The original article contained few errors: Hanuma K.
Karnati’s name was misstated in the author list, references
2 and 55 referred to the wrong sources, and the authors
wanted to expand on their discussion of ChEIs on page
13. These errors have all been updated in the XML, PDF,
and HTML versions of this article.
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